ipharmacy

FDA Safety Alert

Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels

U.S. Food and Drug Administration
October 1, 2026
ID: http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/greenwich-rx-issues-voluntary-nationwide-recall-compounded-glutathione-due-elevated-endotoxin-levels

FDA MedWatch Safety Alert

IMMEDIATE RELEASE - Tomball, Texas – October 1, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of its compounded glutathione to the consumer level. The product is being recalled due to potential elevated endotoxin levels.

Content syndicated from the official FDA MedWatch Safety Alerts and Adverse Event Reporting Program.

View Official Announcement on FDA.gov